ExodusPoint Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,979
| Closed | -$390K | – | 1481 |
|
|
2024
Q3 | $390K | Buy |
+1,979
| New | +$390K | ﹤0.01% | 1192 |
|
|
2024
Q1 | – | Sell |
-38,838
| Closed | -$9.18M | – | 1441 |
|
|
2023
Q4 | $9.18M | Sell |
38,838
-26,296
| -40% | -$6.22M | 0.06% | 186 |
|
|
2023
Q3 | $12.8M | Buy |
65,134
+50,798
| +354% | +$9.96M | 0.12% | 154 |
|
|
2023
Q2 | $3.01M | Sell |
14,336
-45,754
| -76% | -$9.62M | 0.02% | 571 |
|
|
2023
Q1 | $12.1M | Buy |
60,090
+52,271
| +669% | +$10.5M | 0.1% | 176 |
|
|
2022
Q4 | $1.7M | Buy |
+7,819
| New | +$1.7M | 0.02% | 700 |
|
|
2022
Q1 | – | Sell |
-2,997
| Closed | -$1.13M | – | 2200 |
|
|
2021
Q4 | $1.13M | Buy |
+2,997
| New | +$1.13M | 0.01% | 973 |
|
|
2021
Q2 | – | Sell |
-96,183
| Closed | -$27.9M | – | 2343 |
|
|
2021
Q1 | $27.9M | Buy |
96,183
+84,720
| +739% | +$24.6M | 0.41% | 18 |
|
|
2020
Q4 | $2.86M | Sell |
11,463
-49,620
| -81% | -$12.4M | 0.03% | 383 |
|
|
2020
Q3 | $13.8M | Buy |
+61,083
| New | +$13.8M | 0.28% | 37 |
|
|
2019
Q4 | – | Sell |
-1,700
| Closed | -$225K | – | 1527 |
|
|
2019
Q3 | $225K | Buy |
+1,700
| New | +$225K | 0.01% | 1027 |
|